[World Health Organization. http://www.who.int]Search in Google Scholar
[Ayuso MJL, Vazquez BJL, Dowrick Ch et al. Depressive disorders in Europe: prevalence figures from the ODIN study. British Journal of Psychiatry 2001; 179: 308-16.10.1192/bjp.179.4.308]Search in Google Scholar
[American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, 2000 (DSM-IV-TR), Washington, DC: American Psychiatric Association; 2000.]Search in Google Scholar
[The ICD-10 Classification of Mental and Behavioral disorders. Clinical descriptions and diagnostic guidelines. Geneva. Switzerland: World Health Organization; 1992.]Search in Google Scholar
[King M, Nazareth I, Levy G, et al. Prevalence of common mental disorders in general practice attendees across Europe. British Journal of Psychiatry 2008; 192: 362-367.10.1192/bjp.bp.107.039966]Search in Google Scholar
[Papaport MH. Prevalence, recognition and treatment of comorbid depression and anxiety. J Clin Psychiatry 2001; 62 (suppl 24): 6-10.]Search in Google Scholar
[Aartjan T.F, Beekman, Beurs E, et al. Anxiety and Depression in Later Life: Co-Occurrence and communality of risk factors. Am J Psychiatry 2000; 157:89-95.10.1176/ajp.157.1.89]Search in Google Scholar
[Campell RJ. Psychiatric dictionary. The definitive dictionary of psychiatry. Oxford. Ninth edition. 2009.]Search in Google Scholar
[Bernd L, Spitzer RL, Williams JBW, et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. General Hospital Psychiatry 2008; 30: 191-19910.1016/j.genhosppsych.2008.01.001]Search in Google Scholar
[Muller HJ. Anxiety associated with comorbid depression. J Clin Psychiatry 2002; 63 (suppl 14): 22-26]Search in Google Scholar
[Andreescu C, Lenze EJ, Dew MA, et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. British Journal of Psychiatry 2007; 190: 344-34910.1192/bjp.bp.106.027169]Search in Google Scholar
[Katon W, Eh L, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychyiatry 2007; 29:147-5510.1016/j.genhosppsych.2006.11.005]Search in Google Scholar
[Barlow Dh, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behavior Therapy 2004; 35:205-30.10.1016/S0005-7894(04)80036-4]Search in Google Scholar
[Mergl R, Seidscheck I, Allgaier AK, et al. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety 2007; 24 (3): 185-95.10.1002/da.2019216900465]Search in Google Scholar
[Bouček J, Pidrman V. Psychofarmaka v medicíně. Grada. Praha. 2005.]Search in Google Scholar
[Zimmerman M, Dermut WM, Mattia JI. Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. Am J Psychiatry 2000; 157:1337-1340.10.1176/appi.ajp.157.8.133710910803]Search in Google Scholar
[Lydiard RB, Mintzer B. Anxious depression. J Clin Psychiatry 1998; 59 (suppl 18): 10-17.]Search in Google Scholar
[Rosenbaum Jf, Fava M, Nierenberg AA. The pharmacologic treatment of mood disorders. Psychiatr Clin North Am. Annual of Drug Therapy 1994; 1:17-50.]Search in Google Scholar
[Fava M, Rush J. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A Star D Report. Am J Psychiatry 2008; 165: 342-351.10.1176/appi.ajp.2007.0611186818172020]Search in Google Scholar
[Nardi AE, Valença AM, Freire RC, et al. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Braz J Med Biol Res. 2011; Apr 44 (4): 366-73.10.1590/S0100-879X2011000400015]Search in Google Scholar
[Goes FS, McCusker MM, Bienvenu OJ, et al. Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med 2011; Nov 21: 1-11.10.1017/S0033291711002637]Search in Google Scholar
[Jonathan RT, Davidson, MD; Edna B, et al. Comprehensive cognitive behavioral therapy and placebo in generalized social phobia. Arch Gen Psychiatry 2004; 61:1005-1013.10.1001/archpsyc.61.10.1005]Search in Google Scholar
[Levitan RD, Jarrett RB, Schaffer M, et al. Treatment of atypical depression with cognitive therapy or phenelzine. Arch Gen Psychiatry 2000; 57: 1084.10.1001/archpsyc.57.11.1084]Search in Google Scholar
[Rasmussen SA, Eisen JL, Pato MT. Current issues in the pharmacologic management of obsessive compulsive disorder. J Clin Psychiatry 1993; 54 (suppl 6): 4-9.]Search in Google Scholar
[Saric RH, Ninan P, Black DW, et al. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry 2000; 57: 76-82.10.1001/archpsyc.57.1.76]Search in Google Scholar
[Saric RH, Clary HW. Obsessive-complusive disorder with comorbid major depression: a comparison of sertraline and desipramine treatment. Eur Neuropsychopharmacol 1997; (suppl 2): 180.10.1016/S0924-977X(97)88592-6]Search in Google Scholar
[Davidson JRT, Kudler HS, Saunders WB, et al. Symptom and morbidity patters in World War II and Vietnam veterans with post-traumatic stress disorder. Compr Psychiatry 1990; 31:1662-1670.10.1016/0010-440X(90)90020-S]Search in Google Scholar
[Southwick SM, Yehuda R, Giller EL. Characterization of depression in war-related posttraumatic stress disorder. Am J Psychiatry 1991; 148:179-183.]Search in Google Scholar
[Sanderson WC, Beck AT, Beck J. Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am J Psychiatry 1990; 147: 1025-1028.10.1176/ajp.147.8.10252375436]Search in Google Scholar
[Moffitt TE, Harrington HL, Caspi A, et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 Year. Arch Gen Psychiatry 2007; 64:651-660.10.1001/archpsyc.64.6.65117548747]Search in Google Scholar
[Klein E. The role of extended-release benzodiazepines in the treatment of anxiety: A risk-benefit evaluation with focus on extended-release alprazolam. J Clin Psychiatry 2002; 63(suppl 14): 27-33.]Search in Google Scholar
[Goodwin RD, Gorma JM. Psychoparmacologic treatment of generalized anxiety disorder and the risk of major depression. Am J Psychiatry 2002; 159:1935-1937.10.1176/appi.ajp.159.11.193512411233]Search in Google Scholar
[Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002; 63 (11): 963-71.10.4088/JCP.v63n1102]Search in Google Scholar
[Bazire S. Psychotropic drug directory 2012. The professionals pocket handbook and aide memoire. Lloyd-Reinhold Communication LLP, 2012.]Search in Google Scholar